Skip to content
Screener

908 Devices MASS Operating Cash Flow

Operating Cash Flow at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$2.13B+51.9%
WAT
Waters CorporationWAT
$201M+390%
Agilent Technologies logo
Agilent TechnologiesA
$277M+25.3%
Bruker logo
BrukerBRKR
-$77.4M+39.3%
Quanterix Corporation logo
Quanterix CorporationQTRX
-$5.12M+9.5%
Danaher logo
DanaherDHR
$1.53B+14.6%

Other financials

Income statement

See full
Revenue$16.1M+23.3%
Gross profit$8.3M+30.9%
Operating income-$12.8M+15.5%
Net income-$11.9M+10.6%
EPS (diluted)-$0.32+13.5%

Balance sheet

See full
Cash & equivalents$63.0M+2.1%
Total debt$4.3M-3.0%
Total equity$126.8M-14.8%
Total assets$197.5M+3.0%

Cash flow

See full
CapEx$162.0K+32.8%
Free cash flow$3.0M+151%

Valuation

See full
Market cap$364.32M+55.6%
Enterprise value$305.6M+73.0%
P/S+1.6×

Profitability

See full
Gross margin52.2%+3.0pp
Operating margin-69.1%-21.4pp
Net margin-57%+109pp
FCF margin-1.2%-0.6pp

Returns & leverage

See full
Return on equity-25.2%-336pp
Debt / equity0.0×
Current ratio2.7×-2.3×

Where this comes from

Reported directly by 908 Devices in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.

The source filing: 908 Devices’s 10-Q, filed August 11, 2026.

Filed
Aug 11, 2026, 7:20 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001104659-26-093731
Line itemSix Months Ended June 30, 2026Six Months Ended June 30, 2025
Deferred revenue1,241(2,436)
Right-of-use operating lease assets3881,421
Operating lease liabilities(345)(1,484)
Net cash provided by (used in) operating activities4,376(20,803)
Cash flows from investing activities:
Purchases of property and equipment(202)(281)
Purchases of marketable securities(23,350)(59,417)
Acquisition of businesses, net of cash acquired(12,721)

Item 1. Condensed Consolidated Financial Statements (Unaudited)

FAQ

What is 908 Devices's operating cash flow?
908 Devices (MASS) reported operating cash flow of $3.17M in Q2 2026.
How has 908 Devices's operating cash flow changed year-over-year?
908 Devices's operating cash flow increased by 154.8% year-over-year, from -$5.78M to $3.17M.
What is the long-term trend for 908 Devices's operating cash flow?
Over 4 years (2021 to 2025), 908 Devices's operating cash flow has grown at a -3.7% compound annual growth rate (CAGR), from -$29.08M to -$25.01M.
What does operating cash flow mean?
Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.

Ask your AI about 908 Devices's operating cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude